fluorodopa f 18 has been researched along with Cognition Disorders in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergman, J; Brück, A; Johansson, J; Jokinen, P; Karrasch, M; Rinne, JO | 1 |
| Asselin, MC; Bramon-Bosch, E; Broome, M; Grasby, PM; Howes, OD; Johns, L; McGuire, PK; Montgomery, AJ; Murray, RM; Tabraham, P; Valli, I; Valmaggia, L | 1 |
| Benlloc, L; Cuello, D; Fragoso, M; Salazar, G | 1 |
| Aalto, S; Bergman, J; Brück, A; Nurmi, E; Rinne, JO | 1 |
| Koerts, J; Koning, M; Leenders, KL; Portman, AT; van Beilen, M | 1 |
| Bara-Jimenez, W; Brown, AK; Cropley, VL; Fujita, M; Hallett, M; Herscovitch, P; Innis, RB; Nathan, PJ; Pike, VW; Sangare, J; Zhang, XY | 1 |
| Bergman, J; Haaparanta, M; Nurmi, E; Portin, R; Rinne, JO; Ruottinen, H; Solin, O | 1 |
2 trial(s) available for fluorodopa f 18 and Cognition Disorders
| Article | Year |
|---|---|
Cortical 6-[18F]fluoro-L-dopa uptake and frontal cognitive functions in early Parkinson's disease.
Topics: Aging; Cerebral Cortex; Cognition Disorders; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Severity of Illness Index; Statistics as Topic; Tissue Distribution | 2005 |
Cognitive impairment and the brain dopaminergic system in Parkinson disease: [18F]fluorodopa positron emission tomographic study.
Topics: Aged; Caudate Nucleus; Cognition Disorders; Dihydroxyphenylalanine; Dopamine; Female; Frontal Lobe; Humans; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Predictive Value of Tests; Putamen; Reaction Time; Regression Analysis; Task Performance and Analysis; Tomography, Emission-Computed; Verbal Behavior | 2000 |
5 other study(ies) available for fluorodopa f 18 and Cognition Disorders
| Article | Year |
|---|---|
Cognitive slowing in Parkinson's disease is related to frontostriatal dopaminergic dysfunction.
Topics: Aged; Choice Behavior; Cognition Disorders; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Frontal Lobe; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Reaction Time; Statistics, Nonparametric | 2013 |
Elevated striatal dopamine function linked to prodromal signs of schizophrenia.
Topics: Adult; Brain Mapping; Cognition Disorders; Corpus Striatum; Diagnostic and Statistical Manual of Mental Disorders; Dihydroxyphenylalanine; Dominance, Cerebral; Dopamine; Female; Humans; Image Processing, Computer-Assisted; Male; Neuropsychological Tests; Positron-Emission Tomography; Psychiatric Status Rating Scales; Reference Values; Risk Factors; Schizophrenia; Schizotypal Personality Disorder; Young Adult | 2009 |
Neuropsychiatric symptoms in Lewy body diffuse disease: a case report.
Topics: Aged; Antidepressive Agents; Cognition Disorders; Depressive Disorder, Major; Dihydroxyphenylalanine; Hallucinations; Humans; Lewy Body Disease; Male; Neuropsychological Tests | 2011 |
Striatal dopaminergic activity (FDOPA-PET) associated with cognitive items of a depression scale (MADRS) in Parkinson's disease.
Topics: Aged; Brain Chemistry; Caudate Nucleus; Cognition Disorders; Corpus Striatum; Depressive Disorder; Dihydroxyphenylalanine; Disability Evaluation; Dopamine; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Predictive Value of Tests; Putamen; Synaptic Transmission | 2007 |
Pre- and post-synaptic dopamine imaging and its relation with frontostriatal cognitive function in Parkinson disease: PET studies with [11C]NNC 112 and [18F]FDOPA.
Topics: Attention; Benzazepines; Benzofurans; Brain Mapping; Carbon Radioisotopes; Cognition Disorders; Color Perception; Corpus Striatum; Dihydroxyphenylalanine; Discrimination Learning; Dopamine; Fluorine Radioisotopes; Frontal Lobe; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Mental Status Schedule; Nerve Net; Neuropsychological Tests; Parkinson Disease; Pattern Recognition, Visual; Positron-Emission Tomography; Presynaptic Terminals; Problem Solving; Psychomotor Performance; Receptors, Dopamine D1; Synaptic Membranes | 2008 |